Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Emma Weizenbaum, Ph.D.

Concepts (69)

Back to Profile
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Learning Curve120232320.770 Why?
Video Games120212020.610 Why?
Ketoprofen1201380.450 Why?
Tromethamine12013310.450 Why?
Memory1202321910.440 Why?
Tryptamines12013940.430 Why?
Carbazoles120132290.390 Why?
Data Collection1202033180.360 Why?
Parkinson Disease2202128850.330 Why?
Headache4201612610.280 Why?
Analgesics1201310570.270 Why?
Cognition2202170430.260 Why?
Migraine Disorders2201817290.240 Why?
Feasibility Studies2202353000.180 Why?
Activities of Daily Living2202024140.170 Why?
Computers, Handheld120202110.150 Why?
Amitriptyline120161100.130 Why?
Pituitary Diseases120161370.120 Why?
Reproducibility of Results22023201330.110 Why?
Analgesics, Non-Narcotic120163690.110 Why?
Health Services120187560.100 Why?
Self Concept1201810390.100 Why?
Social Stigma120187870.100 Why?
Functional Laterality1201822430.090 Why?
Motivation1202120180.090 Why?
Boston1202393340.090 Why?
Anxiety Disorders1202127390.080 Why?
Neuropsychological Tests1202171160.070 Why?
Choice Behavior120138460.070 Why?
Physician's Role120139250.070 Why?
Neurology120147840.070 Why?
Fellowships and Scholarships1201411340.060 Why?
Patient Participation1201314470.060 Why?
Alzheimer Disease1202387220.050 Why?
Societies, Medical1201339530.050 Why?
Humans1220237659260.040 Why?
Stress Disorders, Post-Traumatic1201846270.040 Why?
Aged520231711630.040 Why?
Depression1201882230.040 Why?
Pain Clinics12016500.030 Why?
Memory Disorders1202311930.030 Why?
Random Allocation1201823940.030 Why?
Censuses120141970.030 Why?
Amyloid beta-Peptides1202338920.020 Why?
Prevalence22018158280.020 Why?
Treatment Outcome12016651940.020 Why?
Demography1201416400.020 Why?
Self Report1202137680.020 Why?
Male620183638150.020 Why?
Female620183961410.020 Why?
Positron-Emission Tomography1202365420.020 Why?
Disease Progression12023136140.020 Why?
Anxiety1202146690.020 Why?
Program Evaluation1201425020.020 Why?
Sex Factors12018106110.010 Why?
Dose-Response Relationship, Drug12016107270.010 Why?
Adult420212230880.010 Why?
Middle Aged420182230160.010 Why?
Age Factors12018183820.010 Why?
Curriculum1201437840.010 Why?
Young Adult22018598570.010 Why?
Longitudinal Studies12016147450.010 Why?
Adolescent22018888110.010 Why?
Practice Guidelines as Topic1201374230.010 Why?
United States22014729090.010 Why?
Physicians1201345910.010 Why?
Cohort Studies12016416800.010 Why?
Aged, 80 and over12018594960.010 Why?
Retrospective Studies12014815370.000 Why?
Weizenbaum's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (69)
Explore
_
Co-Authors (19)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
© 2025 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.